Compare Novavax Inc (NVAX) vs VNET Group Inc (VNET) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Novavax Inc vs VNET Group Inc — how do they compare? Novavax Inc trades at $8.06 (market cap $1.30B), while VNET Group Inc trades at $7.7 (market cap $2.19B). The key difference: VNET Group Inc is the larger of the two by market cap, and Novavax Inc is trading nearer its 52-week high, VNET Group Inc nearer its low. Which is the better fit depends on your goals.
| NVAX | VNET | |
|---|---|---|
Market Cap | $1.30B | $2.19B |
Sector | Health | Technology |
52-Week High | $11.19 | $14.03 |
52-Week Low | $6.22 | $7.34 |
Enterprise Value | $800.50M | $5.32B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Novavax Inc
Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.
Read more on NVAX →About VNET Group Inc
VNET Group, formerly 21Vianet, is a leading carrier-neutral data center services provider in China. It operates a dual-core strategy: a large-scale retail business serving over 7,000 enterprise customers and an aggressive wholesale segment (Hyperscale 2.0) designed to meet the high-density power and cooling demands of large-scale AI and cloud platforms.
Read more on VNET →
